http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013536167-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2013536167-A
titleOfInvention Parenteral preparations of eracitalabine derivatives
abstract The present invention relates to parenteral formulations for certain long chain saturated and monounsaturated fatty acid derivatives of 1-β-D-arabinofuranosylcytosine (cytarabine). In particular, the present invention relates to parenteral pharmaceutical compositions and methods for their preparation to accommodate therapeutically effective doses of the above derivatives that improve compliance in the treatment of cancer.
priorityDate 2010-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9524201-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009215326-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73437561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21696466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46931058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466386161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453918403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451361835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449573737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450513458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447791568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426111618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452458000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407124392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4369442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423325378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6453725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419560480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10964

Total number of triples: 88.